- Home
- PHAR vs VVR Comparison
PHAR vs VVR Comparison
Compare PHAR & VVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- VVR
- Stock Information
- Founded
- PHAR 1988
- VVR 1998
- Country
- PHAR Netherlands
- VVR United States
- Employees
- PHAR N/A
- VVR N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- VVR Trusts Except Educational Religious and Charitable
- Sector
- PHAR Health Care
- VVR Finance
- Exchange
- PHAR Nasdaq
- VVR Nasdaq
- Market Cap
- PHAR 627.5M
- VVR 588.8M
- IPO Year
- PHAR N/A
- VVR N/A
- Fundamental
- Price
- PHAR $9.98
- VVR $3.94
- Analyst Decision
- PHAR Strong Buy
- VVR
- Analyst Count
- PHAR 3
- VVR 0
- Target Price
- PHAR $27.00
- VVR N/A
- AVG Volume (30 Days)
- PHAR 6.0K
- VVR 692.2K
- Earning Date
- PHAR 03-13-2025
- VVR 01-01-0001
- Dividend Yield
- PHAR N/A
- VVR 11.38%
- EPS Growth
- PHAR N/A
- VVR N/A
- EPS
- PHAR N/A
- VVR N/A
- Revenue
- PHAR $285,745,000.00
- VVR N/A
- Revenue This Year
- PHAR $20.08
- VVR N/A
- Revenue Next Year
- PHAR $9.22
- VVR N/A
- P/E Ratio
- PHAR N/A
- VVR N/A
- Revenue Growth
- PHAR 30.64
- VVR N/A
- 52 Week Low
- PHAR $6.65
- VVR $3.55
- 52 Week High
- PHAR $13.20
- VVR $4.38
- Technical
- Relative Strength Index (RSI)
- PHAR 56.13
- VVR 46.73
- Support Level
- PHAR $9.37
- VVR $3.91
- Resistance Level
- PHAR $10.15
- VVR $4.11
- Average True Range (ATR)
- PHAR 0.50
- VVR 0.06
- MACD
- PHAR -0.09
- VVR 0.01
- Stochastic Oscillator
- PHAR 57.53
- VVR 22.73
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About VVR Invesco Senior Income Trust (DE)
Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide a high level of current income, consistent with the preservation of capital. The company invests in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions.